N-(3,5-Dimethylphenyl)-3-Methoxybenzamide (A3B5) Targets TRP-2 and Inhibits Melanogenesis and Melanoma Growth

    April 2011 in “ ˜The œjournal of investigative dermatology/Journal of investigative dermatology ”
    Eunjung Lee, Yun-Sang Lee, Sung Hwan Hwang, Sanghee Kim, Jae Sung Hwang, Taeyoon Kim
    Studysummary This study found that A(3)B(5) downregulates melanin production and suppresses melanoma cell growth by promoting proteasomal degradation of TRP-2. Our plain-language summary of this paper — not a Tressless recommendation.
    The study demonstrated that N-(3,5-Dimethylphenyl)-3-Methoxybenzamide (A3B5) significantly inhibited melanin production and moderately inhibited melanoma growth by targeting and degrading TRP-2. A3B5 reduced tumor size and weight by over 30% in mice and decreased melanoma cell proliferation by inducing G1 cell cycle arrest. The compound showed low cytotoxicity and effectively reduced UVB-induced pigmentation in guinea pigs. These findings suggested that A3B5 could be a potential therapeutic agent for treating hyperpigmentation and melanoma, though it may need to be combined with other treatments for effective melanoma therapy.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results